OptimizeRx Corp OPRX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OPRX is a good fit for your portfolio.
News
-
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
-
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
-
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
-
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
-
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
-
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
-
OptimizeRx to Participate in Upcoming Investor Conferences
-
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
Trading Information
- Previous Close Price
- $9.09
- Day Range
- $8.91–9.58
- 52-Week Range
- $6.92–16.65
- Bid/Ask
- $7.77 / $14.30
- Market Cap
- $162.56 Mil
- Volume/Avg
- 149,534 / 126,278
Key Statistics
- Price/Earnings (Normalized)
- 39.26
- Price/Sales
- 2.14
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 4.63%
Company Profile
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Core
- Total Number of Employees
- 136
- Website
- https://www.optimizerx.com
Comparables
Valuation
|
Metric
|
OPRX
|
LFST
|
TRHC
|
|---|---|---|---|
Price/Earnings (Normalized) | 39.26 | — | — |
Price/Book Value | 1.28 | 1.62 | — |
Price/Sales | 2.14 | 2.13 | 0.78 |
Price/Cash Flow | 18.42 | 133.33 | — |
Price/Earnings
OPRX
LFST
TRHC
Financial Strength
|
Metric
|
OPRX
|
LFST
|
TRHC
|
|---|---|---|---|
Quick Ratio | 10.96 | 1.01 | 1.28 |
Current Ratio | 11.35 | 1.11 | 1.57 |
Interest Coverage | — | −8.74 | −8.04 |
Quick Ratio
OPRX
LFST
TRHC
Profitability
|
Metric
|
OPRX
|
LFST
|
TRHC
|
|---|---|---|---|
Return on Assets (Normalized) | 3.18% | −4.64% | −2.75% |
Return on Equity (Normalized) | 3.64% | −6.76% | — |
Return on Invested Capital (Normalized) | 3.03% | −4.11% | −1.87% |
Return on Assets
OPRX
LFST
TRHC
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Kvkpt | $39.4 Bil | |
VEEV
| Veeva Systems Inc Class A | Nlszcwyp | Znn | $32.1 Bil | |
SOLV
| Solventum Corp | — | Xtdblh | $11.0 Bil | |
MTHRF
| M3 Inc | — | Lkbpry | $8.3 Bil | |
MTHRY
| M3 Inc ADR | — | Zcmspw | $8.2 Bil | |
PMCUF
| Pro Medicus Ltd | — | Bzxcjk | $7.2 Bil | |
HQY
| HealthEquity Inc | — | Qtzmst | $6.9 Bil | |
RCM
| R1 RCM Inc | — | Lcz | $5.0 Bil | |
DOCS
| Doximity Inc Class A | — | Jqyzlc | $4.6 Bil | |
EVH
| Evolent Health Inc Class A | — | Mfgc | $3.4 Bil |